-
Track & Monitor
Coronavirus Disease (COVID-19) Impact on Biopharmaceutical Venture Capital Deals
This report examines the impact of the COVID-19 pandemic on venture capital deals for biopharmaceutical companies. This analysis is critical to understanding how the outbreak of COVID-19 impacted investments and how those VC deal trends may impact current and future venture capital investments.
-
Company Insights
Tech Innovator Profile – 23andMe, Inc
23andMe, Inc. (23andMe) is a personal genomics and biotechnology company that leverages machine learning (ML) technology to provide DNA analysis services.